Mete, Ahmet <br/><br/>
Effects of intravitreal bevacizumab (Avastin) therapy on retrobulbar blood flow parameters in patients with neovascular age-related macular degeneration.  [electronic resource] 

 -  Journal of clinical ultrasound : JCU  Feb 2010 
 - 66-70 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1097-0096 
<br/><br/><label>Standard No.: </label>10.1002/jcu.20650  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Angiogenesis Inhibitors--administration & dosage<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Bevacizumab<br/>Blood Flow Velocity--drug effects<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Injections<br/>Macular Degeneration--complications<br/>Male<br/>Middle Aged<br/>Ophthalmic Artery--diagnostic imaging<br/>Prospective Studies<br/>Regional Blood Flow--drug effects<br/>Retinal Artery--diagnostic imaging<br/>Retinal Neovascularization--diagnosis<br/>Retinal Vein--diagnostic imaging<br/>Treatment Outcome<br/>Ultrasonography, Doppler, Color--methods<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Vitreous Body